SHIRE PHARMACEUTICALS MBC
- Shire Snaps up New York's Foresight Bio in $300M Pink Eye Deal Xconomy
- UPDATE 1-Shire buys US company to access experimental pink eye treatment Reuters - Sectors - Healthcare
- Shire announces plans to move 300 to Eagleview The Chester County Daily Local News - Business
- BRIEF-Shire names Jeff Poulton as CFO Reuters - Sectors - Healthcare
- Meritage Pharma Acquired by Shire Plc for $70 Million The San Diego Business Journal - Headlines - San Diego, CA
- As Shire expands in Lexington, its merger target earns a key drug approval Bizjournals Health Care
- Shire to buy NPS for $5.2 billion to boost rare disease drugs Reuters - Top News
- PRESS DIGEST- New York Times business news - Jan 12 Fidelity - Merger and Acquision News
- <b>Shire</b> May Spend AbbVie Breakup Fee On NPS Pharmaceuticals, Inc.; <b>NPS</b> Surges On Rumor Bio Space - All News
- CEO who oversaw ViroPharma sale named to same role at Idera The Boston Business Journal - Local News - Boston, MA
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on SHIRE PHARMACEUTICALS MBC
- Rate SHIRE PHARMACEUTICALS MBC on their payment behavior
- Ask your network about SHIRE PHARMACEUTICALS MBC with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.